
Sign up to save your podcasts
Or


STAT biotech reporter Jonathan Wosen joins us to discuss gene therapy pioneer Jim Wilson's exit from his decades-long tenure at the University of Pennsylvania. We also discuss the latest news in the life sciences, including the surprising collapse of a gene editing company, Eli Lilly's pitch to consumers, and more.
By STAT4.5
309309 ratings
STAT biotech reporter Jonathan Wosen joins us to discuss gene therapy pioneer Jim Wilson's exit from his decades-long tenure at the University of Pennsylvania. We also discuss the latest news in the life sciences, including the surprising collapse of a gene editing company, Eli Lilly's pitch to consumers, and more.

30,678 Listeners

1,896 Listeners

499 Listeners

9,513 Listeners

6,086 Listeners

394 Listeners

61 Listeners

86 Listeners

34 Listeners

505 Listeners

5,473 Listeners

19 Listeners

48 Listeners

387 Listeners

12 Listeners